Please login to the form below

Not currently logged in

Novo Nordisk resumes Greek insulin supplies

Novo Nordisk will resume supplying its modern insulin products to Greece after the country agreed to raise prices following mandatory price cuts

Novo Nordisk will resume supplying its modern insulin products to Greece after the country agreed to raise its prices on the drugs following mandatory price cuts earlier in the year.

The Danish company, which is the world's biggest maker of insulin, said in an emailed statement that Greece issued a new price bulletin, effective from June 14, for 48 insulin products including Novo Nordisk's modern insulins and pen-based insulins.

The new prices are higher than those dictated by the decree which took effect on May 3, but lower than the average of the three lowest prices in Europe.

Novo Nordisk has deemed this reasonable because "the government has stated it will base future prices in Greece on the average of the three lowest prices in Europe in an upcoming price decree."

"We have therefore accepted the new temporary prices," a company spokesman added. "As a result, we expect that all pharmacies will soon be able to deliver the full range of Novo Nordisk insulin products in Greece."

Novo Nordisk withdrew some of its products from Greece in May after the country's government introduced a mandatory drug price cut of around 25 per cent, which the drugmaker called "unacceptable".

The authorities plan to implement the new drug-pricing scheme by September 1, 2010.

15th June 2010


COVID-19 Updates and Daily News

Featured jobs


Add my company

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

Numbers, navigation, and narratives: digital storytelling in medical communications
Science and storytelling aren’t often seen as compatible. One is based on cold, hard facts, while the other is synonymous with improvisation and theater. However, when done well, storytelling can...
Is this common data mistake killing your digital patient recruitment?
Without realising, you could be falling into the trap of using social data — insights into recent, relevant trends and topics — to inspire your content. Hold up. That sounds...
Dr Henry Skinner
The AMR Action Fund is combating antimicrobial resistance, but much more action is needed
By Henry Skinner, Chief Executive Officer of the AMR Action Fund...